Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Pugsley

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Etanercept. ImmunexM K Pugsley
Journal of Pharmacological and Toxicological Methods|April 28, 2001
Methods of blood flow measurement in the arterial circulatory systemR Tabrizchi, M K Pugsley
Journal of Pharmacological and Toxicological Methods|April 28, 2001
The vascular system. An overview of structure and functionM K Pugsley, R Tabrizchi
British Journal of Pharmacology|June 16, 1999
Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921M K Pugsley, A L Goldin
Cardiovascular Toxicology|April 2, 2003
Commercial development considerations for biotechnology-derived therapeuticsB J Marafino, M K Pugsley
Proceedings of the Western Pharmacology Society|January 1, 1997
Naloxone blockade of sodium currents expressed in Xenopus oocytesM K Pugsley, A L Goldin
Proceedings of the Western Pharmacology Society|December 4, 1998
Time- and voltage-dependent block of sodium channels expressed in Xenopus oocytes by RSD 921, a novel class I antiarrhythmic drugM K Pugsley, A L Goldin
Journal of Pharmacological and Toxicological Methods|May 24, 2012
Methodological innovations expand the safety pharmacology horizonM K Pugsley, M J Curtis
British Journal of Pharmacology|January 1, 1995
Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramilM K Pugsley, D A Saint
European Journal of Pharmacology|April 17, 1998
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channelsM K Pugsley, A L Goldin
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Etanercept. ImmunexM K Pugsley
Journal of Pharmacological and Toxicological Methods|April 28, 2001
Methods of blood flow measurement in the arterial circulatory systemR Tabrizchi, M K Pugsley
Journal of Pharmacological and Toxicological Methods|April 28, 2001
The vascular system. An overview of structure and functionM K Pugsley, R Tabrizchi
British Journal of Pharmacology|June 16, 1999
Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921M K Pugsley, A L Goldin
Cardiovascular Toxicology|April 2, 2003
Commercial development considerations for biotechnology-derived therapeuticsB J Marafino, M K Pugsley
Proceedings of the Western Pharmacology Society|January 1, 1997
Naloxone blockade of sodium currents expressed in Xenopus oocytesM K Pugsley, A L Goldin
Proceedings of the Western Pharmacology Society|December 4, 1998
Time- and voltage-dependent block of sodium channels expressed in Xenopus oocytes by RSD 921, a novel class I antiarrhythmic drugM K Pugsley, A L Goldin
Journal of Pharmacological and Toxicological Methods|May 24, 2012
Methodological innovations expand the safety pharmacology horizonM K Pugsley, M J Curtis
British Journal of Pharmacology|January 1, 1995
Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramilM K Pugsley, D A Saint
European Journal of Pharmacology|April 17, 1998
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channelsM K Pugsley, A L Goldin
Pageof 5